Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer

Stopped Determined that the tumor analysis could not be performed in accordance with the protocol.

Conditions

• Pancreatic Cancer

Interventions

• OTHER: SIGNATERA™ ctDNA testing

Sponsor

Inova Health Care Services

Collaborators

• [object Object]